🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jochen H. Lorch

Northwestern University

ORCID: 0000-0001-9781-6548

Also affiliated with Northwestern Medical Faculty Foundation, Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer”.

Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer

Surgery(2021)10.1016/j.surg.2021.05.055
N/A
0.793DataRank · unranked
20 citations

Abha Aggarwal, Jessica A. Marshall, Justine A. Barletta, Marie Foley Kijewski, Jochen H. Lorch +2 more

33 Unresolved Questions in Nanoscience and Nanotechnology

ACS Nano(2025)10.1021/acsnano.5c12854
N/A
0.520DataRank · unranked
31 citations

Sarah Hurst Petrosko, Natalie Artzi, Koray Aydın, Austin Biaggne, C. Jeffrey Brinker +95 more

Mutational footprint of platinum chemotherapy in a secondary thyroid cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.14.484002
N/A
0.191DataRank · unranked
2 citations

Θεοδώρα Παππά, Jake R. Conway, Jett Crowdis, Brendan Reardon, Felix Dietlein +16 more

Data from Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

(2023)10.1158/1078-0432.c.6530706.v1
N/A
0DataRank · unranked
0 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more

Survivorship therapy needs after radiotherapy for head and neck cancer: surveying opportunities for growth (STRONG)

Supportive Care in Cancer(2025)10.1007/s00520-025-09429-2
N/A
0DataRank · unranked
2 citations

Yangruijue Anna, Zequn Sun, Janine Kingsbury, Katelyn O. Stepan, Adil S. Akthar +7 more

Data from Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

(2023)10.1158/1078-0432.c.6530706
N/A
0DataRank · unranked
0 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more

Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy

Pharmaceutics(2023)10.3390/pharmaceutics15061743
N/A
0DataRank · unranked
20 citations

Jochen H. Lorch, David James VanderWeele, Bin Zhang, Abu Baker

Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0874
N/A
0DataRank · unranked
59 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more